News & Updates

In the treatment of women with early pregnancy loss, adding mifepristone to misoprostol helps reduce the incidence of treatment failure as compared with misoprostol alone, according to a retrospective study.

Administering hyperthermic intraperitoneal chemotherapy (HIPEC) during cytoreductive surgery for recurrent ovarian cancer helps prolong overall survival, according to the results of the phase III open-label CHIPOR trial.

Breast cancer patients undergoing adjuvant endocrine therapy appear to experience symptoms similar in type and intensity to those of symptomatic menopausal women, according to a retrospective study. However, the use of aromatase inhibitors is associated with less severe depressive symptoms.

First-time mothers who sustain life-threatening events during pregnancy, delivery, and up to 42 days postpartum are less likely to have more children, as suggested in a large retrospective study.

A study presented at RCOG 2024 supports the non-removal of incidentally identified cervical polyps, given the low incidence of malignancy and the cost-effectiveness of such approach.

Tranexamic acid was as effective as norethisterone in reducing menstrual blood loss and the duration of menstrual period in women with heavy menstrual bleeding (HMB), according to a study presented at RCOG 2024.

A study suggests that measuring fasting plasma glucose (FPG) and triglyceride levels early in pregnancy can identify women at high risk of gestational diabetes mellitus (GDM).

Data presented at RCOG 2024 reflect the suitability of methoxyflurane – a short-acting analgesic delivered via a handheld, self-administered inhaler device – for use in the performance of minor gynaecology procedures.

Following a healthy prenatal diet, as outlined by the US Dietary Guidelines, helps reduce the likelihood of rapid or slow infant growth, both of which are risk factors for obesity, according to a study.